Pharmacokinetic study of rifabutin in HIV-1-positive Japanese individuals
Not Applicable
- Conditions
- Mycobacteriosis in HIV-positive individuals
- Registration Number
- JPRN-UMIN000001102
- Lead Sponsor
- ational Center for Global Health and Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
Those who have recieved rifabutine within previous 28 days before study enrollment or who are suspected to have allergy for rifabutin.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method